Literature DB >> 31506368

Predictors of Medication-Assisted Treatment Initiation for Opioid Use Disorder in an Interdisciplinary Primary Care Model.

Rebecca E Cantone1, Brian Garvey2, Allison O'Neill2, Joan Fleishman2, Deborah Cohen2, John Muench2, Steffani R Bailey2.   

Abstract

INTRODUCTION: Medication-assisted treatment (MAT) for opioid use disorder (OUD) is underused in primary care. Little is known about patient demographics associated with MAT initiation, particularly among models with an interdisciplinary approach, including behavioral health integration. We hypothesize few disparities in MAT initiation by patient characteristics after implementing this model for OUD.
METHODS: Electronic health record data were used to identify adults with ≥1 primary care visit in 1 of 2 study clinics in a Pacific Northwest academic health system between September 1, 2015 and August 31, 2017 (n = 23,372). Rates of documented OUD diagnosis were calculated. Multivariate logistic regression estimated odds ratios of MAT initiation, defined as ≥1 electronic health record order for buprenorphine or naltrexone, by patient covariates.
RESULTS: Seven percent of the study sample had an OUD diagnosis. Of those patients, 32% had ≥1 MAT order. Patients with documented psychiatric diagnoses or tobacco use had higher odds of initiating MAT (odds ratio [OR] = 1.62, P = .0003; OR = 2.46, P < .0001, respectively). Uninsured, Medicaid, and Medicare patients had lower odds than those commercially insured (OR = 0.53, 0.38, and 0.31, respectively; P < .0001). Patients who were older, of a race/ethnicity other than non-Hispanic white, had documented diabetes, and had documented asthma or chronic obstructive pulmonary disease showed lower odds of initiation. DISCUSSION: MAT initiation varied by patient characteristics, including disparities by insurance coverage and race/ethnicity. The addition of behavioral health did not eliminate disparities in care, but higher odds of initiation among those with a documented psychiatric diagnosis may suggest this model reaches some vulnerable populations. Additional research is needed to further examine these findings. © Copyright 2019 by the American Board of Family Medicine.

Entities:  

Keywords:  Addiction Medicine; Health Care Disparities; Mental Health; Northwestern United States; Opioid-Related Disorders; Primary Health Care

Mesh:

Year:  2019        PMID: 31506368      PMCID: PMC6754209          DOI: 10.3122/jabfm.2019.05.190012

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  23 in total

Review 1.  Implementing dual diagnosis services for clients with severe mental illness.

Authors:  R E Drake; S M Essock; A Shaner; K B Carey; K Minkoff; L Kola; D Lynde; F C Osher; R E Clark; L Rickards
Journal:  Psychiatr Serv       Date:  2001-04       Impact factor: 3.084

Review 2.  Retention in medication-assisted treatment for opiate dependence: A systematic review.

Authors:  Christine Timko; Nicole R Schultz; Michael A Cucciare; Lisa Vittorio; Christina Garrison-Diehn
Journal:  J Addict Dis       Date:  2015-10-14

3.  Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates.

Authors:  William C Becker; Lynn E Sullivan; Jeanette M Tetrault; Rani A Desai; David A Fiellin
Journal:  Drug Alcohol Depend       Date:  2007-12-11       Impact factor: 4.492

Review 4.  Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.

Authors:  Richard P Mattick; Courtney Breen; Jo Kimber; Marina Davoli
Journal:  Cochrane Database Syst Rev       Date:  2014-02-06

Review 5.  Medication-assisted treatment of opioid use disorder: review of the evidence and future directions.

Authors:  Hilary Smith Connery
Journal:  Harv Rev Psychiatry       Date:  2015 Mar-Apr       Impact factor: 3.732

Review 6.  Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990-2014: A systematic review and meta-analysis.

Authors:  Harry Man Xiong Lai; Michelle Cleary; Thiagarajan Sitharthan; Glenn E Hunt
Journal:  Drug Alcohol Depend       Date:  2015-05-28       Impact factor: 4.492

Review 7.  Prescription opioid abuse: a literature review of the clinical and economic burden in the United States.

Authors:  Roxanne Meyer; Anisha M Patel; Stacy K Rattana; Tiffany P Quock; Samir H Mody
Journal:  Popul Health Manag       Date:  2014-12       Impact factor: 2.459

Review 8.  Medication-assisted treatment with buprenorphine: assessing the evidence.

Authors:  Cindy Parks Thomas; Catherine Anne Fullerton; Meelee Kim; Leslie Montejano; D Russell Lyman; Richard H Dougherty; Allen S Daniels; Sushmita Shoma Ghose; Miriam E Delphin-Rittmon
Journal:  Psychiatr Serv       Date:  2014-02-01       Impact factor: 3.084

9.  Changes in Quality of Life following Buprenorphine Treatment: Relationship with Treatment Retention and Illicit Opioid Use.

Authors:  Shannon Gwin Mitchell; Jan Gryczynski; Robert P Schwartz; C Patrick Myers; Kevin E O'Grady; Yngvild K Olsen; Jerome H Jaffe
Journal:  J Psychoactive Drugs       Date:  2015 Apr-Jun

10.  Estimating the costs of opioid abuse and dependence from an employer perspective: a retrospective analysis using administrative claims data.

Authors:  J Bradford Rice; Noam Y Kirson; Amie Shei; Alice Kate G Cummings; Katharine Bodnar; Howard G Birnbaum; Rami Ben-Joseph
Journal:  Appl Health Econ Health Policy       Date:  2014-08       Impact factor: 2.561

View more
  10 in total

Review 1.  The American Opioid Epidemic in Special Populations: Five Examples.

Authors:  Carlos Blanco; Mir M Ali; Aaron Beswick; Karen Drexler; Cheri Hoffman; Christopher M Jones; Tisha R A Wiley; Allan Coukell
Journal:  NAM Perspect       Date:  2020-10-26

2.  Improving Management of Opioid Use Disorder Training With Novel Resident Co-PCP Model.

Authors:  Kristopher Azevedo; Rebecca E Cantone; Brian T Garvey
Journal:  PRiMER       Date:  2022-08-22

3.  Dual mental health diagnoses predict the receipt of medication-assisted opioid treatment: Associations moderated by state Medicaid expansion status, race/ethnicity and gender, and year.

Authors:  George Pro; Jeff Utter; Shane Haberstroh; Julie A Baldwin
Journal:  Drug Alcohol Depend       Date:  2020-03-07       Impact factor: 4.492

4.  Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems.

Authors:  Denise M Boudreau; Gwen Lapham; Eric A Johnson; Jennifer F Bobb; Abigail G Matthews; Jennifer McCormack; David Liu; Cynthia I Campbell; Rebecca C Rossom; Ingrid A Binswanger; Bobbi Jo Yarborough; Julia H Arnsten; Chinazo O Cunningham; Joseph E Glass; Mark T Murphy; Mohammad Zare; Rulin C Hechter; Brian Ahmedani; Jordan M Braciszewski; Viviana E Horigian; José Szapocznik; Jeffrey H Samet; Andrew J Saxon; Robert P Schwartz; Katharine A Bradley
Journal:  J Subst Abuse Treat       Date:  2020-03

5.  Depressive symptoms and use of HIV care and medication-assisted treatment among people with HIV who inject drugs.

Authors:  Oleksandr Zeziulin; Katie R Mollan; Bonnie E Shook-Sa; Brett Hanscom; Kathryn E Lancaster; Kostyantyn Dumchev; Vivian F Go; Viet A Chu; Tetiana Kiriazova; Zulvia Syarif; Sergii Dvoryak; Sarah A Reifeis; Erica Hamilton; Riza Sarasvita; Scott Rose; Paul Richardson; William Clarke; Carl A Latkin; David S Metzger; Irving F Hoffman; William C Miller
Journal:  AIDS       Date:  2021-03-01       Impact factor: 4.632

6.  Mental Health and Psychosocial Needs of Patients Being Treated for Opioid Use Disorder in a Primary Care Residency Clinic.

Authors:  Stephanie A Hooker; Michelle D Sherman; Mary Lonergan-Cullum; Adam Sattler; Bruce S Liese; Kathryn Justesen; Tanner Nissly; Robert Levy
Journal:  J Prim Care Community Health       Date:  2020 Jan-Dec

7.  Characterizing the social support and functioning of a low-threshold medication for opioid use disorder treatment cohort at intake.

Authors:  William Oles; Marcus Alexander; Navin Kumar; Benjamin Howell; Patrick G O'Connor; Lynn M Madden; Declan T Barry
Journal:  BMC Psychiatry       Date:  2022-04-02       Impact factor: 3.630

8.  Tailoring services in opioid treatment programs for patients involved in America's criminal justice system: national associations and variation by state and Medicaid expansion status.

Authors:  George Pro; Brooke E E Montgomery; Nickolas Zaller
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-06-19

9.  Opioid Use Disorder and Assessment of Patient Interactions Among Family Medicine Residents, Medical Students, and Physician Assistant Students.

Authors:  John G Spangler; Catherine N Shull; Carol A Hildebrandt; Keli Beck Jones; Andrew L Brewer; Mark P Knudson; Gail S Marion; Julienne K Kirk
Journal:  MedEdPORTAL       Date:  2020-11-12

10.  Addiction Medicine Practice-Based Research Network (AMNet): Assessment Tools and Quality Measures.

Authors:  Diana E Clarke; Adila Ibrahim; Benjamin Doty; Sejal Patel; Debbie Gibson; Anna Pagano; Laura Thompson; Amy B Goldstein; Frank Vocci; Robert P Schwartz
Journal:  Subst Abuse Rehabil       Date:  2021-06-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.